US5912015A
(en)
*
|
1992-03-12 |
1999-06-15 |
Alkermes Controlled Therapeutics, Inc. |
Modulated release from biocompatible polymers
|
US5656297A
(en)
*
|
1992-03-12 |
1997-08-12 |
Alkermes Controlled Therapeutics, Incorporated |
Modulated release from biocompatible polymers
|
US5674534A
(en)
*
|
1992-06-11 |
1997-10-07 |
Alkermes, Inc. |
Composition for sustained release of non-aggregated erythropoietin
|
US5711968A
(en)
*
|
1994-07-25 |
1998-01-27 |
Alkermes Controlled Therapeutics, Inc. |
Composition and method for the controlled release of metal cation-stabilized interferon
|
US5716644A
(en)
*
|
1992-06-11 |
1998-02-10 |
Alkermes, Inc. |
Composition for sustained release of non-aggregated erythropoietin
|
US6514533B1
(en)
|
1992-06-11 |
2003-02-04 |
Alkermas Controlled Therapeutics, Inc. |
Device for the sustained release of aggregation-stabilized, biologically active agent
|
WO1994012158A1
(en)
*
|
1992-12-02 |
1994-06-09 |
Alkermes Controlled Therapeutics, Inc. |
Controlled release growth hormone containing microspheres
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US6087324A
(en)
|
1993-06-24 |
2000-07-11 |
Takeda Chemical Industries, Ltd. |
Sustained-release preparation
|
US6913767B1
(en)
|
1993-10-25 |
2005-07-05 |
Genentech, Inc. |
Compositions for microencapsulation of antigens for use as vaccines
|
US6080429A
(en)
*
|
1993-10-25 |
2000-06-27 |
Genentech, Inc. |
Method for drying microspheres
|
CN1157562A
(zh)
*
|
1994-09-09 |
1997-08-20 |
武田药品工业株式会社 |
含有一种肽金属盐的缓释制剂
|
EP1080718A1
(de)
*
|
1995-06-07 |
2001-03-07 |
Alkermes Controlled Therapeutics, Inc. |
Zusammensetzung zur verzögerten Abgabe von menschlichem Wachstumshormon
|
BR9608542A
(pt)
*
|
1995-06-07 |
1999-11-30 |
Alkermes Inc |
Composição para a liberação sustentada de hormónio do crescimento humano
|
EP0831786A2
(de)
*
|
1995-06-07 |
1998-04-01 |
Alkermes Controlled Therapeutics, Inc. |
Vorrichtung zur freisetzung eines gegen aggregation stabilisierten biologisch aktiven stoffs
|
WO1997001331A2
(en)
|
1995-06-27 |
1997-01-16 |
Takeda Chemical Industries, Ltd. |
Method of producing sustained-release preparation
|
AU710347B2
(en)
*
|
1995-08-31 |
1999-09-16 |
Alkermes Controlled Therapeutics, Inc. |
Composition for sustained release of an agent
|
SE505146C2
(sv)
*
|
1995-10-19 |
1997-06-30 |
Biogram Ab |
Partiklar för fördröjd frisättning
|
KR100210509B1
(ko)
*
|
1996-01-10 |
1999-07-15 |
성재갑 |
지속성 동물 성장 호르몬 제형 및 이의 제조 방법
|
DE69717263T2
(de)
|
1996-03-28 |
2003-07-24 |
Takeda Chemical Industries Ltd |
Zubereitung mit verzögerter freisetzung und deren herstellung
|
US6515016B2
(en)
*
|
1996-12-02 |
2003-02-04 |
Angiotech Pharmaceuticals, Inc. |
Composition and methods of paclitaxel for treating psoriasis
|
US6495579B1
(en)
|
1996-12-02 |
2002-12-17 |
Angiotech Pharmaceuticals, Inc. |
Method for treating multiple sclerosis
|
CA2275422A1
(en)
|
1996-12-20 |
1998-07-02 |
Takeda Chemical Industries, Ltd. |
Method of producing a sustained-release preparation
|
AU5609798A
(en)
*
|
1996-12-20 |
1998-07-17 |
Alza Corporation |
Injectable depot gel composition and method of preparing the composition
|
US6306826B1
(en)
|
1997-06-04 |
2001-10-23 |
The Regents Of The University Of California |
Treatment of heart failure with growth hormone
|
US5989463A
(en)
*
|
1997-09-24 |
1999-11-23 |
Alkermes Controlled Therapeutics, Inc. |
Methods for fabricating polymer-based controlled release devices
|
US6191107B1
(en)
|
1997-09-26 |
2001-02-20 |
Takeda Chemical Industries, Ltd. |
Complex of human growth hormone and zinc
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US20020017295A1
(en)
*
|
2000-07-07 |
2002-02-14 |
Weers Jeffry G. |
Phospholipid-based powders for inhalation
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
SE512663C2
(sv)
|
1997-10-23 |
2000-04-17 |
Biogram Ab |
Inkapslingsförfarande för aktiv substans i en bionedbrytbar polymer
|
EP0966271A1
(de)
*
|
1997-11-06 |
1999-12-29 |
Orbon Corporation |
Stabilisierte, getröcknete arzneimittelzubereitungen zur wirkstofffreisetzung und verfahren zu deren herstellung
|
ATE233097T1
(de)
|
1997-11-07 |
2003-03-15 |
Chiron Corp |
Verfahren zur herstellung von igf-i formulierungen mit verzögerter freisetzung
|
US6168570B1
(en)
*
|
1997-12-05 |
2001-01-02 |
Micrus Corporation |
Micro-strand cable with enhanced radiopacity
|
EP2050762A3
(de)
|
1998-03-10 |
2009-07-08 |
Genentech, Inc. |
Neue Polypeptide und für diese kodierende Nukleinsäuren
|
US20030180368A1
(en)
*
|
1998-03-14 |
2003-09-25 |
Cenes Drug Delivery Limited |
Production of microparticles
|
US6733767B2
(en)
|
1998-03-19 |
2004-05-11 |
Merck & Co., Inc. |
Liquid polymeric compositions for controlled release of bioactive substances
|
KR20010042079A
(ko)
|
1998-03-20 |
2001-05-25 |
다케다 야쿠힌 고교 가부시키가이샤 |
생리학적으로 활성인 폴리펩티드의 서방 제제 및 그것의제조 방법
|
US6284282B1
(en)
*
|
1998-04-29 |
2001-09-04 |
Genentech, Inc. |
Method of spray freeze drying proteins for pharmaceutical administration
|
ES2292242T5
(es)
|
1998-05-15 |
2011-05-04 |
Genentech, Inc. |
Utilizaciones terapéuticas de polipéptidos homólogos de il-17.
|
EP3112468A1
(de)
|
1998-05-15 |
2017-01-04 |
Genentech, Inc. |
Il-17-homologe polypeptide und therapeutische verwendung davon
|
US20020172678A1
(en)
|
2000-06-23 |
2002-11-21 |
Napoleone Ferrara |
EG-VEGF nucleic acids and polypeptides and methods of use
|
US6696063B1
(en)
*
|
1998-12-30 |
2004-02-24 |
Applied Research Systems Ars Holding N.V. |
Treatment of HIV-associated dysmorphia/dysmetabolic syndrome (HADDS) with or without lipodystrophy
|
CA2689696C
(en)
|
1999-02-26 |
2013-08-06 |
Novartis Vaccines And Diagnostics, Inc. |
Microemulsions with adsorbed macromolecules and microparticles
|
US6451347B1
(en)
|
1999-03-01 |
2002-09-17 |
Alkermes Controlled Therapeutics, Inc. |
Method for purifying human growth hormone
|
US7018654B2
(en)
*
|
1999-03-05 |
2006-03-28 |
New River Pharmaceuticals Inc. |
Pharmaceutical composition containing an active agent in an amino acid copolymer structure
|
US6716452B1
(en)
|
2000-08-22 |
2004-04-06 |
New River Pharmaceuticals Inc. |
Active agent delivery systems and methods for protecting and administering active agents
|
US6444223B1
(en)
|
1999-05-28 |
2002-09-03 |
Alkermes Controlled Therapeutics, Inc. |
Method of producing submicron particles of a labile agent and use thereof
|
EP1949890A3
(de)
|
1999-06-04 |
2011-05-18 |
ALZA Corporation |
Implantierbare Gelzusammensetzungen und Herstellungsverfahren dafür
|
NZ515911A
(en)
*
|
1999-06-04 |
2004-02-27 |
Alza Corp |
Implantable gel compositions and method of manufacture
|
US6586011B2
(en)
|
1999-06-10 |
2003-07-01 |
Southpac Trust International, Inc. |
Microencapsulated plasminogen activators
|
AU5152700A
(en)
|
1999-06-15 |
2001-01-02 |
Genentech Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US7713739B1
(en)
|
2000-11-17 |
2010-05-11 |
Novartis Vaccines And Diagnostics, Inc. |
Microparticle-based transfection and activation of dendritic cells
|
US6310166B1
(en)
|
1999-08-12 |
2001-10-30 |
Closure Medical Corporation |
Sterilized cyanoacrylate solutions containing thickeners
|
FR2797784B1
(fr)
*
|
1999-08-27 |
2001-11-30 |
Mainelab |
Procede d'encapsulation de matieres actives par coacervation de polymeres en solvant organique non-chlore
|
MXPA02002439A
(es)
*
|
1999-09-16 |
2002-07-30 |
Novo Nordisk As |
Composicion para fertilizacion in vitro.
|
CA2383144A1
(en)
|
1999-09-17 |
2001-03-29 |
Takeda Chemical Industries, Ltd. |
Process for producing protein powder
|
US6458387B1
(en)
*
|
1999-10-18 |
2002-10-01 |
Epic Therapeutics, Inc. |
Sustained release microspheres
|
US6284283B1
(en)
|
1999-10-21 |
2001-09-04 |
Alkermes Controlled Therapeutics, Inc. |
Method of producing sub-micron particles of biologically active agents and uses thereof
|
CA2496312A1
(en)
|
1999-12-01 |
2001-06-07 |
Kevin P. Baker |
Colon tumour marker pro4799 polypeptides and nucleic acids encoding the same
|
US20040071715A1
(en)
*
|
1999-12-15 |
2004-04-15 |
Schwendeman Steven P. |
Polymer compositions that stabilize and control the release of formaldehyde-treated vaccine antigens
|
US6743446B2
(en)
*
|
1999-12-15 |
2004-06-01 |
The Ohio State University Research Foundation |
Methods for stabilizing biologically active agents encapsulated in biodegradable controlled-release polymers
|
DK1897945T3
(da)
|
1999-12-23 |
2012-05-07 |
Genentech Inc |
IL-17 homologe polypeptider og terapeutiske anvendelser deraf.
|
AU785055B2
(en)
*
|
2000-01-13 |
2006-09-07 |
Genentech Inc. |
Novel stra6 polypeptides
|
US7029700B2
(en)
*
|
2000-01-14 |
2006-04-18 |
Brown University Research Foundation |
Micronized freeze-dried particles
|
US6821520B2
(en)
*
|
2000-02-15 |
2004-11-23 |
Allergan, Inc. |
Clostridial toxin therapy for Hashimoto's thyroiditis
|
US6358513B1
(en)
|
2000-02-15 |
2002-03-19 |
Allergan Sales, Inc. |
Method for treating Hashimoto's thyroiditis
|
US6773711B2
(en)
*
|
2000-02-15 |
2004-08-10 |
Allergan, Inc. |
Botulinum toxin therapy for Hashimoto's thyroiditis
|
US6524580B1
(en)
|
2000-02-15 |
2003-02-25 |
Allergan Sales, Inc. |
Method for treating thyroid disorders
|
US6319506B1
(en)
|
2000-02-22 |
2001-11-20 |
Allergan, Sales, Inc. |
Method for treating hypercalcemia
|
US20030211974A1
(en)
*
|
2000-03-21 |
2003-11-13 |
Brodbeck Kevin J. |
Gel composition and methods
|
US6740520B2
(en)
|
2000-03-21 |
2004-05-25 |
Genentech, Inc. |
Cytokine receptor and nucleic acids encoding the same
|
US20040086970A1
(en)
*
|
2000-03-22 |
2004-05-06 |
Genentech, Inc. |
Novel cytokine receptors and nucleic acids encoding the same
|
DE60120372T2
(de)
*
|
2000-03-24 |
2007-07-05 |
Genentech Inc., San Francisco |
Verwendung von insulin zur behandlung von knorpelkrankheiten
|
US6998137B2
(en)
*
|
2000-04-07 |
2006-02-14 |
Macromed, Inc. |
Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix
|
AU2001259111B2
(en)
|
2000-04-19 |
2005-12-08 |
Durect Corporation |
Sustained release formulations comprising growth hormone
|
PT1280520E
(pt)
*
|
2000-05-10 |
2014-12-16 |
Novartis Ag |
Pós à base de fosfolípidos para administração de fármacos
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
US6264987B1
(en)
*
|
2000-05-19 |
2001-07-24 |
Alkermes Controlled Therapeutics Inc. Ii |
Method for preparing microparticles having a selected polymer molecular weight
|
US6495164B1
(en)
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
US20040033241A1
(en)
*
|
2000-06-02 |
2004-02-19 |
Allergan, Inc. |
Controlled release botulinum toxin system
|
US20050214327A1
(en)
*
|
2000-06-02 |
2005-09-29 |
Allergan, Inc. |
Neurotoxin-containing suppositories and related methods
|
US20040170665A1
(en)
*
|
2000-06-02 |
2004-09-02 |
Allergan, Inc. |
Intravitreal botulinum toxin implant
|
AU6531101A
(en)
|
2000-06-02 |
2001-12-17 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US6306423B1
(en)
|
2000-06-02 |
2001-10-23 |
Allergan Sales, Inc. |
Neurotoxin implant
|
KR100381382B1
(ko)
*
|
2000-06-28 |
2003-04-23 |
한국과학기술원 |
지속적 약물조절방출이 가능한 생분해성 미립담체 및 그의제조방법
|
US6719970B1
(en)
|
2000-07-10 |
2004-04-13 |
Alkermes Controlled Therapeutics, Inc. |
Method of generating cartilage
|
AU8111301A
(en)
*
|
2000-08-07 |
2002-02-18 |
Inhale Therapeutic Syst |
Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
|
US6296842B1
(en)
|
2000-08-10 |
2001-10-02 |
Alkermes Controlled Therapeutics, Inc. |
Process for the preparation of polymer-based sustained release compositions
|
US6479065B2
(en)
|
2000-08-10 |
2002-11-12 |
Alkermes Controlled Therapeutics, Inc. |
Process for the preparation of polymer-based sustained release compositions
|
DE60140625D1
(de)
*
|
2000-08-15 |
2010-01-07 |
Univ Illinois |
Verfahren zur herstellung von mikropartikeln
|
EP2014298A3
(de)
|
2000-08-24 |
2009-10-07 |
Genentech, Inc. |
Interleukin-22-Polypeptide, Nukleinsäuren zu deren Codierung und Verfahren zur Behandlung von Bauchspeicheldrüsenerkrankungen
|
EP1944317A3
(de)
|
2000-09-01 |
2008-09-17 |
Genentech, Inc. |
Sekretierte und Transmembran-Polypeptide sowie Nukleinsäure zu deren Kodierung
|
US6824822B2
(en)
*
|
2001-08-31 |
2004-11-30 |
Alkermes Controlled Therapeutics Inc. Ii |
Residual solvent extraction method and microparticles produced thereby
|
US6471995B1
(en)
*
|
2000-09-27 |
2002-10-29 |
Alkermes Controlled Therapeutics, Inc. Ii |
Apparatus and method for preparing microparticles using liquid-liquid extraction
|
SE517421C2
(sv)
|
2000-10-06 |
2002-06-04 |
Bioglan Ab |
Mikropartiklar, lämpade för parenteral administration, väsentligen bestående av stärkelse med minst 85 % amylopektin och med reducerad molekylvikt, samt framställning därav
|
AU2001294459A1
(en)
|
2000-10-06 |
2002-04-15 |
Jagotec Ag |
A controlled-release, parenterally administrable microparticle preparation
|
SE517422C2
(sv)
|
2000-10-06 |
2002-06-04 |
Bioglan Ab |
Farmaceutiskt acceptabel stärkelse
|
US6673580B2
(en)
*
|
2000-10-27 |
2004-01-06 |
Genentech, Inc. |
Identification and modification of immunodominant epitopes in polypeptides
|
DE60138641D1
(de)
|
2000-10-27 |
2009-06-18 |
Baxter Healthcare Sa |
Herstellung von mikrokügelchen
|
US8394813B2
(en)
|
2000-11-14 |
2013-03-12 |
Shire Llc |
Active agent delivery systems and methods for protecting and administering active agents
|
SE518007C2
(sv)
|
2000-11-16 |
2002-08-13 |
Bioglan Ab |
Förfarande för framställning av mikropartiklar
|
SE518008C2
(sv)
*
|
2000-11-16 |
2002-08-13 |
Bioglan Ab |
Parenteralt administrerbara mikropartiklar och förfarande för framställning av desamma
|
US20020114843A1
(en)
*
|
2000-12-27 |
2002-08-22 |
Ramstack J. Michael |
Preparation of microparticles having improved flowability
|
US20070142325A1
(en)
*
|
2001-01-08 |
2007-06-21 |
Gustavsson Nils O |
Starch
|
US20040022861A1
(en)
*
|
2001-01-30 |
2004-02-05 |
Williams Robert O. |
Process for production of nanoparticles and microparticles by spray freezing into liquid
|
US7824700B2
(en)
*
|
2001-02-23 |
2010-11-02 |
Genentech, Inc. |
Erodible polymers for injection
|
FR2822834B1
(fr)
*
|
2001-04-02 |
2005-02-25 |
Flamel Tech Sa |
Suspension colloidale de nanoparticules a base de copolymeres amphiphile pour la vectorisation de principes actifs et leur mode de preparation
|
US6558702B2
(en)
*
|
2001-04-13 |
2003-05-06 |
Alkermes Controlled Therapeutics, Inc. |
Method of modifying the release profile of sustained release compositions
|
US20060269602A1
(en)
*
|
2001-04-13 |
2006-11-30 |
Dasch James R |
Method of modifying the release profile of sustained release compositions
|
US6887857B2
(en)
*
|
2001-04-27 |
2005-05-03 |
Scimed Life Systems, Inc. |
Microparticle protection of therapeutic agents
|
WO2002092619A2
(en)
|
2001-05-14 |
2002-11-21 |
The Gouvernment Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Modified growth hormone
|
US20070160576A1
(en)
|
2001-06-05 |
2007-07-12 |
Genentech, Inc. |
IL-17A/F heterologous polypeptides and therapeutic uses thereof
|
ES2554106T3
(es)
|
2001-06-21 |
2015-12-16 |
Genentech, Inc. |
Formulación de liberación sostenida
|
US20080026068A1
(en)
*
|
2001-08-16 |
2008-01-31 |
Baxter Healthcare S.A. |
Pulmonary delivery of spherical insulin microparticles
|
ES2307779T3
(es)
*
|
2001-08-16 |
2008-12-01 |
Baxter International Inc. |
Formulaciones de microparticulas a base de propelentes.
|
US20060014697A1
(en)
*
|
2001-08-22 |
2006-01-19 |
Travis Mickle |
Pharmaceutical compositions for prevention of overdose or abuse
|
US7169752B2
(en)
*
|
2003-09-30 |
2007-01-30 |
New River Pharmaceuticals Inc. |
Compounds and compositions for prevention of overdose of oxycodone
|
US7105181B2
(en)
|
2001-10-05 |
2006-09-12 |
Jagotec, Ag |
Microparticles
|
DE60227691D1
(de)
*
|
2001-11-01 |
2008-08-28 |
Nektar Therapeutics |
Sprühtrocknungsverfahren
|
EP1446100B1
(de)
*
|
2001-11-14 |
2011-05-04 |
Durect Corporation |
Injizierbare depotzusammensetzungen und deren verwendung
|
KR20040058101A
(ko)
*
|
2001-11-14 |
2004-07-03 |
알자 코포레이션 |
카테터 주입가능한 데포 조성물 및 그의 용도
|
US20070196415A1
(en)
*
|
2002-11-14 |
2007-08-23 |
Guohua Chen |
Depot compositions with multiple drug release rate controls and uses thereof
|
SI1458360T1
(sl)
|
2001-12-19 |
2011-08-31 |
Novartis Ag |
Pulmonalno dajanje aminoglikozidov
|
US7255874B1
(en)
|
2001-12-21 |
2007-08-14 |
Closure Medical Corporation |
Biocompatible polymers and adhesives: compositions, methods of making and uses related thereto
|
AU2003217367B2
(en)
*
|
2002-02-08 |
2005-09-08 |
Alkermes Controlled Therapeutics, Inc. |
Polymer-based compositions for sustained release
|
EP1485477B1
(de)
|
2002-02-25 |
2009-05-13 |
Genentech, Inc. |
Neuer typ-1-cytokinrezeptor glm-r
|
SE0201599D0
(sv)
|
2002-03-21 |
2002-05-30 |
Skyepharma Ab |
Microparticles
|
WO2003085092A2
(en)
*
|
2002-04-01 |
2003-10-16 |
Law Peter K |
Cellular transplantation for heart regeneration
|
FR2840614B1
(fr)
|
2002-06-07 |
2004-08-27 |
Flamel Tech Sa |
Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques
|
AR039729A1
(es)
|
2002-06-25 |
2005-03-09 |
Alza Corp |
Formulaciones de deposito de corta duracion
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
FR2843117B1
(fr)
*
|
2002-07-30 |
2004-10-15 |
Flamel Tech Sa |
Polyaminoacides fonctionnalises par au moins un groupement hydrophobe et leurs applications notamment therapeutiques
|
DE60226282T2
(de)
*
|
2002-07-31 |
2009-09-17 |
Alza Corp., Mountain View |
Injizierbare depotzusammensetzungen und deren verwendung
|
WO2004011054A2
(en)
*
|
2002-07-31 |
2004-02-05 |
Alza Corporation |
Injectable multimodal polymer depot compositions and uses thereof
|
JP2006508127A
(ja)
*
|
2002-11-06 |
2006-03-09 |
アルザ・コーポレーション |
制御された放出性デポー剤配合物
|
CA2512052C
(en)
*
|
2002-12-31 |
2016-06-21 |
Altus Pharmaceuticals Inc. |
Human growth hormone crystals and methods for preparing them
|
ES2349779T5
(es)
|
2003-04-04 |
2013-11-26 |
Genentech, Inc. |
Formulaciones de anticuerpos y de proteínas a concentración elevada
|
DE10315538A1
(de)
*
|
2003-04-04 |
2004-10-21 |
Siemens Ag |
Teilchen mit einer Membran
|
ATE390126T1
(de)
*
|
2003-05-01 |
2008-04-15 |
Ltt Bio Pharma Co Ltd |
Zubereitungen mit verzögerter freigabe enthaltend zink, und herstellung derselben
|
FR2855521B1
(fr)
*
|
2003-05-28 |
2005-08-05 |
Flamel Tech Sa |
Polyaminoacides fonctionnalises par au moins un groupement h ydrophobe et leurs applications notamment therapeutiques.
|
US20070184084A1
(en)
*
|
2003-05-30 |
2007-08-09 |
Guohua Chen |
Implantable elastomeric caprolactone depot compositions and uses thereof
|
EP1643968A1
(de)
*
|
2003-05-30 |
2006-04-12 |
ALZA Corporation |
Implantierbare elastomere depot-zusammensetzungen, ihre verwendungen und herstellungsverfahren
|
EP1636593B9
(de)
|
2003-06-06 |
2009-12-16 |
Genentech, Inc. |
Modulation der wechselwirkung zwischen hgf-beta-kette und c-met
|
KR100835786B1
(ko)
|
2003-07-08 |
2008-06-09 |
제넨테크, 인크. |
Il-17a/f 이종 폴리펩티드 및 그의 치료 용도
|
SG135204A1
(en)
*
|
2003-07-18 |
2007-09-28 |
Baxter Int |
Methods for fabrication, uses and compositions of small spherical particles prepared by controlled phase separation
|
US20050142205A1
(en)
*
|
2003-07-18 |
2005-06-30 |
Julia Rashba-Step |
Methods for encapsulating small spherical particles prepared by controlled phase separation
|
US20070092452A1
(en)
*
|
2003-07-18 |
2007-04-26 |
Julia Rashba-Step |
Methods for fabrication, uses, compositions of inhalable spherical particles
|
US20050048127A1
(en)
*
|
2003-07-22 |
2005-03-03 |
Larry Brown |
Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof
|
WO2005020933A2
(en)
|
2003-09-02 |
2005-03-10 |
University Of South Florida |
Nanoparticles for drug-delivery
|
FR2860516B1
(fr)
*
|
2003-10-03 |
2006-01-13 |
Flamel Tech Sa |
Homopolyaminoacides telecheliques fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques
|
ES2349743T3
(es)
*
|
2003-10-10 |
2011-01-11 |
Novo Nordisk A/S |
Derivados de la il-21.
|
US20050106214A1
(en)
*
|
2003-11-14 |
2005-05-19 |
Guohua Chen |
Excipients in drug delivery vehicles
|
US20050281879A1
(en)
*
|
2003-11-14 |
2005-12-22 |
Guohua Chen |
Excipients in drug delivery vehicles
|
US20050118206A1
(en)
*
|
2003-11-14 |
2005-06-02 |
Luk Andrew S. |
Surfactant-based gel as an injectable, sustained drug delivery vehicle
|
FR2862536B1
(fr)
*
|
2003-11-21 |
2007-11-23 |
Flamel Tech Sa |
Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques
|
FR2862535B1
(fr)
*
|
2003-11-21 |
2007-11-23 |
Flamel Tech Sa |
Formulations pharmaceutiques pour la liberation prolongee d'interleukines et leurs applications therapeutiques
|
FR2862541B1
(fr)
*
|
2003-11-21 |
2007-04-20 |
Flamel Tech Sa |
Formulations pharmaceutiques pour la liberation prolongee d'interferons et leurs applications therapeutiques
|
US7309500B2
(en)
*
|
2003-12-04 |
2007-12-18 |
The Board Of Trustees Of The University Of Illinois |
Microparticles
|
JP2008507252A
(ja)
|
2003-12-11 |
2008-03-13 |
ジェネンテック・インコーポレーテッド |
C−met二量体化及び活性化を阻害するための方法と組成物
|
US7481997B1
(en)
|
2004-02-12 |
2009-01-27 |
Montana State University |
Snow mountain virus genome sequence, virus-like particles and methods of use
|
EP2075254A1
(de)
|
2004-03-30 |
2009-07-01 |
NsGene A/S |
Therapeutische Verwendung des Wachstumsfaktors NsG33
|
WO2005110425A1
(en)
|
2004-04-15 |
2005-11-24 |
Alkermes, Inc. |
Polymer-based sustained release device
|
EP1749039A1
(de)
*
|
2004-04-23 |
2007-02-07 |
Amgen Inc. |
Niedermolekulare polymilchsäurepolymere
|
WO2005107714A2
(en)
*
|
2004-05-05 |
2005-11-17 |
Alkermes Controlled Therapeutics, Inc. |
Method of forming microparticles that include a bisphosphonate and a polymer
|
AU2005244851B2
(en)
*
|
2004-05-12 |
2010-08-26 |
Baxter Healthcare S.A. |
Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1
|
CN103393601A
(zh)
|
2004-05-12 |
2013-11-20 |
巴克斯特国际公司 |
含有蛋白并在高浓度蛋白下显示可注射性的微球体
|
US8728525B2
(en)
|
2004-05-12 |
2014-05-20 |
Baxter International Inc. |
Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
|
JP2007537284A
(ja)
*
|
2004-05-12 |
2007-12-20 |
バクスター インターナショナル インコーポレイテッド |
核酸マイクロスフェア、その生成および送達
|
WO2006013462A2
(en)
*
|
2004-07-30 |
2006-02-09 |
Nsgene A/S |
Growth factors nsg28, nsg30, and nsg32
|
EP1781264B1
(de)
|
2004-08-04 |
2013-07-24 |
Evonik Corporation |
Verfahren zur herstellung von abgabevorrichtungen und damit erhaltene vorrichtungen
|
US7964219B2
(en)
*
|
2004-08-12 |
2011-06-21 |
Qps, Llc |
Pharmaceutical compositions for controlled release delivery of biologically active compounds
|
US7919577B2
(en)
|
2004-10-27 |
2011-04-05 |
Colorado Seminary |
Adrenocorticotropic hormone analogs and related methods
|
US7748343B2
(en)
|
2004-11-22 |
2010-07-06 |
The Board Of Trustees Of The University Of Illinois |
Electrohydrodynamic spraying system
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
EP1861125A2
(de)
*
|
2005-03-23 |
2007-12-05 |
Nektar Therapeutics Al, Corporation |
Konjugate eines hgh-teils und peg-derivate
|
MX2007013356A
(es)
*
|
2005-04-27 |
2008-03-26 |
Baxter Int |
Microparticulas modificadas en la superficie y metodos de formacion y uso de las mismas.
|
US20060271262A1
(en)
*
|
2005-05-24 |
2006-11-30 |
Mclain Harry P Iii |
Wireless agricultural network
|
WO2008018854A2
(en)
*
|
2005-06-06 |
2008-02-14 |
The Rockefeller University |
Bactiophage lysins for bacillus anthracis
|
WO2006132788A2
(en)
|
2005-06-06 |
2006-12-14 |
Genentech, Inc. |
Transgenic models for different genes and their use for gene characterization
|
WO2006135915A2
(en)
|
2005-06-13 |
2006-12-21 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions for treating degenerative bone disorders
|
MX348154B
(es)
|
2005-06-21 |
2017-05-30 |
Xoma (Us) Llc |
Anticuerpos de enlace a il-1-beta y fragmentos de los mismos.
|
US20070015689A1
(en)
*
|
2005-06-23 |
2007-01-18 |
Alza Corporation |
Complexation of metal ions with polypeptides
|
US7582291B2
(en)
*
|
2005-06-30 |
2009-09-01 |
The Rockefeller University |
Bacteriophage lysins for Enterococcus faecalis, Enterococcus faecium and other bacteria
|
AU2006280321A1
(en)
|
2005-08-15 |
2007-02-22 |
Genentech, Inc. |
Gene disruptions, compositions and methods relating thereto
|
US8362086B2
(en)
|
2005-08-19 |
2013-01-29 |
Merial Limited |
Long acting injectable formulations
|
US8105585B2
(en)
*
|
2005-08-24 |
2012-01-31 |
The Rockefeller Universtiy |
Ply-GBS mutant lysins
|
AU2006335053A1
(en)
|
2005-11-21 |
2007-07-19 |
Genentech, Inc. |
Novel gene disruptions, compositions and methods relating thereto
|
BRPI0621124A2
(pt)
|
2005-12-22 |
2011-11-29 |
Genentech Inc |
métodos para recuperação de uma proteìna de ligação à heparina
|
AU2006330833A1
(en)
*
|
2005-12-23 |
2007-07-05 |
Altus Pharmaceuticals Inc. |
Compositions comprising polycation-complexed protein crystals and methods of treatment using them
|
WO2007114979A2
(en)
|
2006-02-17 |
2007-10-11 |
Genentech, Inc. |
Gene disruptons, compositions and methods relating thereto
|
EP2389947A1
(de)
|
2006-03-23 |
2011-11-30 |
Novartis AG |
Antitumorzellenantigen-Antikörper-Therapeutika
|
AU2007238186B2
(en)
|
2006-04-10 |
2014-01-09 |
Genentech, Inc. |
Disheveled PDZ modulators
|
US20090288176A1
(en)
|
2006-04-19 |
2009-11-19 |
Genentech, Inc. |
Novel Gene Disruptions, Compositions and Methods Relating Thereto
|
US20070281031A1
(en)
*
|
2006-06-01 |
2007-12-06 |
Guohan Yang |
Microparticles and methods for production thereof
|
WO2008019346A2
(en)
*
|
2006-08-04 |
2008-02-14 |
Baxter International Inc. |
Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
|
EP3421031A1
(de)
|
2006-08-09 |
2019-01-02 |
Intarcia Therapeutics, Inc |
Osmotisches verabreichungssystem mit kolbenanordnung
|
WO2008060786A2
(en)
*
|
2006-10-06 |
2008-05-22 |
Baxter International Inc. |
Microencapsules containing surface-modified microparticles and methods of forming and using the same
|
JP5645409B2
(ja)
|
2006-12-20 |
2014-12-24 |
ゾーマ (ユーエス) リミテッド ライアビリティ カンパニー |
IL−1β関連疾患の治療方法
|
JP2010522196A
(ja)
*
|
2007-03-22 |
2010-07-01 |
アルカームズ,インコーポレイテッド |
コアセルベーション工程
|
US8808747B2
(en)
*
|
2007-04-17 |
2014-08-19 |
Baxter International Inc. |
Nucleic acid microparticles for pulmonary delivery
|
CN101715340A
(zh)
|
2007-04-23 |
2010-05-26 |
精达制药公司 |
促胰岛素释放肽的混悬制剂及其应用
|
US20080264641A1
(en)
*
|
2007-04-30 |
2008-10-30 |
Slabaugh Billy F |
Blending Fracturing Gel
|
US20080317865A1
(en)
*
|
2007-06-20 |
2008-12-25 |
Alkermes, Inc. |
Quench liquids and washing systems for production of microparticles
|
CN101361968B
(zh)
|
2007-08-06 |
2011-08-03 |
健能隆医药技术(上海)有限公司 |
白介素-22在治疗脂肪肝中的应用
|
KR100845009B1
(ko)
*
|
2007-08-07 |
2008-07-08 |
한국생명공학연구원 |
전하를 띠는 물질이 고착된 다공성 고분자 입자 및 그제조방법
|
EP2185701A4
(de)
*
|
2007-08-15 |
2011-03-02 |
Amunix Operating Inc |
Zusammensetzungen und verfahren zur veränderung von eigenschaften biologisch aktiver polypeptide
|
US20090061009A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Joseph Schwarz |
Composition and Method of Treatment of Bacterial Infections
|
PL2391650T3
(pl)
|
2007-12-20 |
2015-03-31 |
Xoma Us Llc |
Sposoby leczenia dny
|
EP2222281B1
(de)
|
2007-12-20 |
2018-12-05 |
Evonik Corporation |
Verfahren zur herstellung von mikropartikeln mit geringer restlösemittelmenge
|
EP2240155B1
(de)
|
2008-02-13 |
2012-06-06 |
Intarcia Therapeutics, Inc |
Vorrichtungen, formulierungen und verfahren zur freisetzung mehrerer wirkstoffe
|
US9107815B2
(en)
|
2008-02-22 |
2015-08-18 |
Allergan, Inc. |
Sustained release poloxamer containing pharmaceutical compositions
|
US20110182946A1
(en)
*
|
2008-03-17 |
2011-07-28 |
Board Of Regents, The University Of Texas System |
Formation of Nanostructured Particles of Poorly Water Soluble Drugs and Recovery by Mechanical Techniques
|
AU2009270695A1
(en)
|
2008-07-17 |
2010-01-21 |
Ap Pharma |
Methods for enhancing the stability of polyorthoesters and their formulations
|
US8367427B2
(en)
|
2008-08-20 |
2013-02-05 |
Baxter International Inc. |
Methods of processing compositions containing microparticles
|
US20100047292A1
(en)
*
|
2008-08-20 |
2010-02-25 |
Baxter International Inc. |
Methods of processing microparticles and compositions produced thereby
|
US8323685B2
(en)
*
|
2008-08-20 |
2012-12-04 |
Baxter International Inc. |
Methods of processing compositions containing microparticles
|
US8323615B2
(en)
|
2008-08-20 |
2012-12-04 |
Baxter International Inc. |
Methods of processing multi-phasic dispersions
|
WO2010085607A1
(en)
*
|
2009-01-23 |
2010-07-29 |
Surmodics Pharmaceuticals, Inc. |
Continuous double emulsion process for making microparticles
|
US8680050B2
(en)
*
|
2009-02-03 |
2014-03-25 |
Amunix Operating Inc. |
Growth hormone polypeptides fused to extended recombinant polypeptides and methods of making and using same
|
LT2393828T
(lt)
|
2009-02-03 |
2017-01-25 |
Amunix Operating Inc. |
Prailginti rekombinantiniai polipeptidai ir juos apimančios kompozicijos
|
US8703717B2
(en)
*
|
2009-02-03 |
2014-04-22 |
Amunix Operating Inc. |
Growth hormone polypeptides and methods of making and using same
|
KR101183262B1
(ko)
|
2009-04-22 |
2012-09-14 |
(주)알테오젠 |
체내 지속성을 유지함으로 체내 반감기가 증가된 단백질 또는 펩티드 융합체, 및 이를 이용하여 체내 반감기를 증가시키는 방법
|
US9849188B2
(en)
|
2009-06-08 |
2017-12-26 |
Amunix Operating Inc. |
Growth hormone polypeptides and methods of making and using same
|
SI2462246T1
(en)
|
2009-09-28 |
2018-01-31 |
Intarcia Therapeutics, Inc. |
Fast-setting and / or cessation of substantially unchanged delivery of the product
|
CN102656266B
(zh)
*
|
2009-10-15 |
2016-08-03 |
霍夫曼-拉罗奇有限公司 |
具有改变的受体特异性的嵌合成纤维细胞生长因子
|
US8771693B2
(en)
|
2009-10-27 |
2014-07-08 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for the generation and use of conformation-specific antibodies
|
US8637637B2
(en)
*
|
2010-01-12 |
2014-01-28 |
Bill Nai-Chau Sun |
Fc fusion proteins of human growth hormone
|
EP2523672B1
(de)
|
2010-01-15 |
2016-07-13 |
Rutgers, the State University of New Jersey |
Verwendung von vanadiumverbindungen für beschleunigte knochenheilung
|
KR20180000342A
(ko)
|
2010-03-22 |
2018-01-02 |
제넨테크, 인크. |
단백질-함유 제제의 안정화에 유용한 조성물 및 방법
|
MX2012012743A
(es)
|
2010-05-03 |
2012-11-23 |
Genentech Inc |
Composiciones y metodos utiles para reducir la viscosidad de formulaciones que contienen proteina.
|
MY161390A
(en)
|
2010-06-24 |
2017-04-14 |
Genentech Inc |
Compositions and methods containing alkylglycosides for stabilizing protein-containing formulations
|
CN102380091A
(zh)
|
2010-08-31 |
2012-03-21 |
健能隆医药技术(上海)有限公司 |
白介素-22在治疗病毒性肝炎中的应用
|
WO2012041328A1
(en)
|
2010-10-01 |
2012-04-05 |
Nsgene A/S |
Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
|
WO2012045274A1
(en)
|
2010-10-08 |
2012-04-12 |
Shanghai Kexin Biotech Co., Ltd. |
Moesin modulators and uses thereof
|
JP5913326B2
(ja)
|
2010-10-08 |
2016-04-27 |
シャンハイ クーシン バイオテック カンパニー,リミテッド |
モエシン断片の診断的および治療的使用
|
WO2012092539A2
(en)
|
2010-12-31 |
2012-07-05 |
Takeda Pharmaceutical Company Limited |
Antibodies to dll4 and uses thereof
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
WO2012149334A2
(en)
|
2011-04-27 |
2012-11-01 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for the generation and use of conformation-specific antibodies
|
CN109078182B
(zh)
|
2011-10-31 |
2022-08-12 |
弗·哈夫曼-拉罗切有限公司 |
抗体制剂
|
CN104144946A
(zh)
|
2011-12-19 |
2014-11-12 |
爱克索马美国有限责任公司 |
治疗痤疮的方法
|
AU2013208003B2
(en)
|
2012-01-09 |
2017-12-14 |
The Scripps Research Institute |
Ultralong complementarity determining regions and uses thereof
|
CN104411717A
(zh)
|
2012-01-09 |
2015-03-11 |
斯克利普斯研究所 |
具有超长cdr3s的人源化抗体
|
RU2664700C2
(ru)
|
2012-05-10 |
2018-08-21 |
Пейнреформ Лтд. |
Депо-составы местного анестетика и способы их получения
|
AU2014240063B2
(en)
|
2013-03-15 |
2019-04-11 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for the generation and use of conformation-specific antibodies
|
AU2014290361B2
(en)
|
2013-07-18 |
2019-04-18 |
Taurus Biosciences, Llc |
Humanized antibodies with ultralong complementarity determining regions
|
EP3022224A2
(de)
|
2013-07-18 |
2016-05-25 |
Fabrus, Inc. |
Antikörper mit ultralangen komplementaritätsbestimmenden regionen
|
AU2014318579A1
(en)
|
2013-09-13 |
2016-04-14 |
The California Institute For Biomedical Research |
Modified therapeutic agents and compositions thereof
|
AU2014337367B2
(en)
|
2013-10-15 |
2020-04-30 |
The Scripps Research Institute |
Peptidic chimeric antigen receptor T cell switches and uses thereof
|
EP3057991B8
(de)
|
2013-10-15 |
2019-09-04 |
The Scripps Research Institute |
Chimäre antigenrezeptor-t-zell-schalter und verwendungen davon
|
CN104623639A
(zh)
|
2013-11-07 |
2015-05-20 |
健能隆医药技术(上海)有限公司 |
白介素22二聚体在制备治疗胰腺炎药物中的应用
|
CN104623637A
(zh)
|
2013-11-07 |
2015-05-20 |
健能隆医药技术(上海)有限公司 |
Il-22二聚体在制备静脉注射药物中的应用
|
EP3079668A1
(de)
|
2013-12-09 |
2016-10-19 |
Durect Corporation |
Pharmazeutisch aktive wirkstoffkomplexe, polymerkomplexe und zusammensetzungen und verfahren damit
|
EP3082797A4
(de)
|
2013-12-18 |
2017-12-13 |
The California Institute for Biomedical Research |
Modifizierte therapeutika, geheftete peptidlipidkonjugate und zusammensetzungen davon
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
NL2014230B1
(en)
|
2015-02-04 |
2016-10-12 |
Stichting Vu-Vumc |
Wound healing formulation.
|
MA41629A
(fr)
|
2015-03-04 |
2018-01-09 |
Center For Human Reproduction |
Compositions et méthodes d'utilisation de l'hormone anti-müllérienne pour le traitement de l'infertilité
|
WO2016154621A1
(en)
|
2015-03-26 |
2016-09-29 |
The California Institute For Biomedical Research |
SWITCHABLE NON-scFv CHIMERIC RECEPTORS, SWITCHES, AND USES THEREOF
|
US11091546B2
(en)
|
2015-04-15 |
2021-08-17 |
The Scripps Research Institute |
Optimized PNE-based chimeric receptor T cell switches and uses thereof
|
KR102650751B1
(ko)
|
2015-06-03 |
2024-03-22 |
인타르시아 세라퓨틱스 인코포레이티드 |
임플란트 배치 및 제거 시스템들
|
WO2016205488A1
(en)
|
2015-06-17 |
2016-12-22 |
The California Institute For Biomedical Research |
Modified therapeutic agents and compositions thereof
|
EP3442562B1
(de)
|
2016-04-15 |
2022-09-21 |
Evive Biotechnology (Shanghai) Ltd |
Ein il-22-dimer zur verwendung in der behandlung der nekrotisierenden enterokolitis
|
SG10201913699QA
(en)
|
2016-05-16 |
2020-03-30 |
Intarcia Therapeutics Inc |
Glucagon-receptor selective polypeptides and methods of use thereof
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
CN110267982B
(zh)
|
2016-10-19 |
2024-02-23 |
斯克利普斯研究所 |
具有人源化靶向部分和/或经过优化的嵌合抗原受体相互作用结构域的嵌合抗原受体效应细胞开关以及其用途
|
AU2018206539A1
(en)
|
2017-01-03 |
2019-07-18 |
Intarcia Therapeutics, Inc. |
Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug
|
JP2022521840A
(ja)
|
2019-04-01 |
2022-04-12 |
ジェネンテック, インコーポレイテッド |
タンパク質含有製剤を安定化するための組成物および方法
|
US20210047425A1
(en)
|
2019-08-12 |
2021-02-18 |
Purinomia Biotech, Inc. |
Methods and compositions for promoting and potentiating t-cell mediated immune responses through adcc targeting of cd39 expressing cells
|
WO2021081440A2
(en)
|
2019-10-24 |
2021-04-29 |
Minotaur Therapeutics, Inc. |
Chimeric cytokine modified antibodies and methods of use thereof
|
KR20220140711A
(ko)
|
2020-01-13 |
2022-10-18 |
듀렉트 코퍼레이션 |
불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법
|
WO2022232321A1
(en)
|
2021-04-28 |
2022-11-03 |
Minotaur Therapeutics, Inc. |
Humanized chimeric bovine antibodies and methods of use
|
EP4333872A1
(de)
|
2021-05-06 |
2024-03-13 |
Hoba Therapeutics ApS |
Vorbeugung und behandlung von chemotherapie-induzierten neuropathischen schmerzen
|
WO2023104960A1
(en)
|
2021-12-10 |
2023-06-15 |
Hoba Therapeutics Aps |
Treatment of nociceptive pain
|